Bcli stock nasdaq
Find the latest Aberdeen Standard Bloomberg All (BCI) stock quote, history, news and other vital information to help you with your stock trading and investing. ValuEngine cut shares of Brainstorm Cell Therapeutics (NASDAQ:BCLI) from a buy rating to a hold rating in a research note released on Wednesday, ValuEngine reports. Separately, Maxim Group restated a buy rating and set a $9.00 price target on shares of Brainstorm Cell Therapeutics in a research note on Tuesday, May 14th. Shares of BCLI […] Summary quote, performance, and fundamental analysis for NASDAQ:BCLI Brainstorm Cell Therapeutics Inc.